CanniMed.
Canadian public licensed producer of medical cannabis
- Reports this week
- 3
- Active events
- 2
- Connections
- 61
What's happening
Active this week
Earlier this month
-
A direct financial comparison of market performance was conducted between CanniMed and Prestige Consumer Healthcare.Some support2 reports
-
Curaleaf launched a hostile takeover bid for Aurora, while market signals were discussed comparing company sizes involving Nvidia and CanniMed.Some support2 reports1 development inside
One to three months ago
-
Curaleaf launched a hostile bid of $4 per share regarding the ongoing corporate developments involving CanniMed.Some support1 report
-
Aurora Cannabis and Tilray are driving market growth and leading innovations in European cannabis therapies.Some support2 reports
-
MarketBeat is reporting on analyst recommendations for Aurora Cannabis, noting that both CanniMed and the company based in Shandong are small-cap medical companies.Well supported4 reports
-
Trump's administration is looking to reclassify marijuana, which could reshape the pot industry, involving Aurora Cannabis and TD Cowen.Some support2 reports2 developments inside
-
Rate reduction affects market prices and sustainability for CanniMed.Some support1 report
Gone quiet
No new reports in 90+ days-
CanniMed primarily operates in Canada and is headquartered in Edmonton.Some support1 report
-
Aurora Cannabis, which operates the San Rafael brand, is headquartered in Edmonton.Some support2 reports1 development inside
-
CanniMed, which operates the San Rafael brand, is facing market challenges as Canadian reimbursement rates dropped 30%.Some support1 report
-
Aurora Cannabis announced plans to enter new emerging markets, including Switzerland and Austria.Speculative1 report
-
Rumors surfaced regarding Aurora Cannabis potentially partnering with New Zealand-based MedLeaf Therapeutics for distribution in Germany, with misinformation also circulating on investing.com.Speculative1 report
-
Aurora Cannabis launched two new products in Poland on June 24, 2025.Speculative1 report
-
Aurora Cannabis, a Canadian company, operates in Europe, with a distribution center located in Brampton.Some support1 report
-
Aurora Cannabis, a Canadian medical cannabis company, issued a press release from Edmonton.Some support2 reports
-
Aurora Cannabis's Brampton facility received EU-GMP certification, positioning the company in the international medical cannabis market.Some support1 report
-
Aurora Cannabis's medical cannabis segment saw higher international revenues supported by domestic demand.Some support2 reports
-
Aurora Cannabis, a Canadian medical cannabis company, launched its Whistler Cannabis Co. brand in Australia.Some support4 reports
-
Aurora Cannabis has successfully navigated regulatory challenges and achieved strong performance in key European markets, including developments related to Poland.Some support2 reports4 developments inside
-
CanniMed launched high potency medical cannabis products in Poland.Speculative1 report
No events began in the chosen period. Widen it, or reset.
Around CanniMed this week
News at the entities that move CanniMed most-
Tilray OperationalBoth InterCure and Tilray are small-cap healthcare providers.Moves CanniMed
-
Poland OperationalForesight is expanding its presence and investing in a data center project in Warsaw, Poland.Moves CanniMed
-
Edmonton Shared contextSystemic healthcare failures are being reported in Alberta, specifically concerning infectious disease issues at the University of Alberta Hospital.Moves CanniMed
-
Europe Shared contextThe European Central Bank is forced to raise interest rates due to energy price shocks from the Iran war and an influx of Chinese exports.Moves CanniMed
-
Toronto Stock Exchange Shared contextFairfax utilizes TSX facilities for NCIB commencement.Moves CanniMed
-
Caribbean Shared contextJackson Alexander Weech was appointed Director General of the Bahamas Ministry of Tourism to focus on regional tourism growth.Moves CanniMed
Connections
The 14 strongest of 61, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Poland Operational
CanniMed operates within Poland's medical cannabis market, leveraging its regulatory environment and market size.
-
Tilray Operational
Both companies are described as competitors in the cannabis-based therapies market facing shared market challenges.
-
Miguel Martin Mentioned together
The evidence details Miguel Martin's professional roles (CEO/Executive Chairman) at Aurora Cannabis Inc., but provides no direct evidence linking these roles to CanniMed.
-
Edmonton Shared context
The company is officially headquartered in the city of Edmonton, Alberta.
-
Europe Shared context
CanniMed operates within the regulatory and market context of Europe.
-
Toronto Stock Exchange Shared context
CanniMed is a company whose shares are traded on the Toronto Stock Exchange.
-
Shandong Shared context
The company operates within the geographical and market context of the province, where both are small-cap medical entities.
-
Caribbean Shared context
CanniMed operates as a wholesale medical cannabis distributor within the Caribbean market.
Show all 14 connections
-
MarketBeat Mentioned together
Evidence is insufficient to determine a coupling relationship between MarketBeat and CanniMed.
-
Argentina Shared context
CanniMed operates within the geographical and market context of Argentina.
-
Miguel Martin Mentioned together
No direct relationship between CanniMed and Miguel Martin was observed in the provided evidence.
-
San Rafael Mentioned together
No direct relationship between CanniMed and San Rafael was observed in the evidence.
-
Baader Bank Aktiengesellschaft Mentioned together
Evidence only describes A's action regarding a third party (Aurora Cannabis) and does not establish any connection between A and B.
-
Curaleaf Mentioned together
The evidence focuses exclusively on Curaleaf's hostile takeover bids for Aurora and provides no information regarding CanniMed.
History
Events by the month they beganSeptember 2026
3 events- CanniMed and Recordati Industria Chimica E Farmaceutica are both companies operating within the healthcare sector.
- Market expansion details for Tilray Brands, Aurora, and Trulieve into Argentina, Canada, and Connecticut.
- A direct financial comparison of market performance was conducted between CanniMed and Prestige Consumer Healthcare.
August 2026
2 eventsShow 1 earlier month
June 2026
16 events- Aurora Cannabis and Tilray are driving market growth and leading innovations in European cannabis therapies.
- MarketBeat is reporting on analyst recommendations for Aurora Cannabis, noting that both CanniMed and the company based in Shandong are small-cap medical companies.
- Trump's administration is looking to reclassify marijuana, which could reshape the pot industry, involving Aurora Cannabis and TD Cowen.
- CanniMed primarily operates in Canada and is headquartered in Edmonton.
- Aurora Cannabis, which operates the San Rafael brand, is headquartered in Edmonton.
- CanniMed, which operates the San Rafael brand, is facing market challenges as Canadian reimbursement rates dropped 30%.
- Aurora Cannabis announced plans to enter new emerging markets, including Switzerland and Austria.
- Rumors surfaced regarding Aurora Cannabis potentially partnering with New Zealand-based MedLeaf Therapeutics for distribution in Germany, with misinformation also circulating on investing.com.
- Aurora Cannabis launched two new products in Poland on June 24, 2025.
- Aurora Cannabis, a Canadian company, operates in Europe, with a distribution center located in Brampton.
- Aurora Cannabis, a Canadian medical cannabis company, issued a press release from Edmonton.
- Aurora Cannabis's Brampton facility received EU-GMP certification, positioning the company in the international medical cannabis market.
- Aurora Cannabis's medical cannabis segment saw higher international revenues supported by domestic demand.
- Aurora Cannabis, a Canadian medical cannabis company, launched its Whistler Cannabis Co. brand in Australia.
- Aurora Cannabis has successfully navigated regulatory challenges and achieved strong performance in key European markets, including developments related to Poland.
- CanniMed launched high potency medical cannabis products in Poland.